Medtronic (MDT): EVP & Pres Neuroscience exercised options on 27K shares
Brett A. Wall, EVP & Pres Neuroscience at Medtronic, reported an option exercise of 27K shares.
- 27K
- Shares
- Traded
- May 26, 2026
- Filed
- May 29, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 7, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
- Mar 20, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
- Apr 28, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 15, 2026CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
- May 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 18, 2026, Medtronic plc (“Medtronic” or the “Company”) announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.”
What came next
- Jun 3, 2026Company filing · Form 8-K · ResultsReported its results
- Jun 8, 2026Insider · 1 personInsiders: 2 sales (~$337K)
- Jul 8, 2026InsiderOfficer sold ~$258K of MDT shares in the open market
- Jul 30, 2026CongressDisclosed sale of MDT — reported range $1,001 - $15,000
- Aug 20, 2026FDARecall: Brand Name: MiniMed Flex Product Name: MiniMed Flex Insulin Pump Model/Catalog Numbers: MMT-8062; MMT-8072 Product Description: The MiniMed Flex pump is an alt…
- Aug 21, 2026FDAFDA device clearance: Affera Integrated Mapping System
- Aug 24, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
- Aug 28, 2026FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
- Aug 31, 2026FDARecall: Medtronic Biopsy Needle Kit, REF: 9733068, Passive, Sterile EO, Rxonly
- Aug 31, 2026FDARecall: Medtronic NDI Passive Spheres REF: 8801075, Sterile EO, 5/Tray 12 Pk., Rxonly
- Aug 31, 2026FDARecall: Medtronic NDI Passive Spheres REF: 8801074, Sterile EO, 4/Tray 12 Pk., Rxonly
- Aug 31, 2026FDARecall: Medtronic NDI Passive Spheres REF: 8801071, Sterile EO, 1/Tray 12 pk., Rxonly
- Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
- Sep 2, 2026FDARecall: Generic Name: MiniMed Go App Generic Name: MiniMed Go App Model/Catalog Number: MMT-8600 (iOS), MMT-8601 (Android) Software Version: Software version 1.2.1 Pro…
- Sep 4, 2026FDAFDA device clearance: ApexCut Blade with Automated EM Tracking (187BL4012EM);ApexCut Blade with Automated EM Tracking (187BL4040EM);ApexCut Blade with Automated EM Tracking (1…
- Sep 8, 2026FDARecall: InterStim Percutaneous Extensions EXT 3560022 ISTM II PERC 3560022 EXT 3560030 ISTM MICRO PERC 3560030
- Sep 8, 2026FDARecall: InterStim SureScan MRI Leads 978A1 & 978B1: LEAD 978A128 ISTM MICRO 28CM SSMRI TINED 978A128 LEAD 978A133 ISTM MICRO 33CM SSMRI TINED 978A133 LEAD 978A141 ISTM…
- Sep 11, 2026FDARecall: CareLink Clinic, REF: MMT-7350
- Sep 15, 2026FDAFDA device clearance: LigaSure RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
- Sep 16, 2026InsiderOfficer sold ~$139K of MDT shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Medtronic
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.
Other recent filings by Brett A. Wall, EVP & Pres Neuroscience
- SEC Form 4 at Medtronic (MDT)Jan 27, 2025
- SEC Form 4 at Medtronic (MDT)Jan 10, 2025
- SEC Form 4 at Medtronic (MDT)Jan 10, 2025
The full history of Brett A. Wall, EVP & Pres Neuroscience is on the profile page.
How this filing works
Explore the data
Common questions
Which Medtronic (MDT) insider traded, and how much?
Brett A. Wall, EVP & Pres Neuroscience at Medtronic, reported an option exercise of 27K shares. Not an open-market trade.
When did it happen, and when was it made public?
Traded: May 26, 2026. Filed: May 29, 2026. That is 3 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Medtronic recently?
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MDT page.
Does this mean MDT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Medtronic
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 4Sep 18, 2026
- SEC Form 144Sep 16, 2026
Everything OQRO holds on this company is on its MDT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
